translatepress-multilingual domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gonaviance/public_html/wp-includes/functions.php on line 6114wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gonaviance/public_html/wp-includes/functions.php on line 6114In a peer-reviewed study believed to be the first of its kind published, a research team led by […]
In a new study led by Johns Hopkins Medicine, the experimental drug RK-33 has demonstrated promise in treating […]
As part of the new national Cancer AI Alliance (CAIA), scientists from the Sidney Kimmel Comprehensive Cancer Center at […]
A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help […]
By tracking the changes in prostate cancer cells over time, researchers at the Johns Hopkins Kimmel Cancer Center have […]
People with operable non-small cell lung cancers have a reduced risk of death and disease recurrence if they […]
Researchers from the Johns Hopkins Kimmel Cancer Center have found age-related changes in skin cells contribute to the […]
In a study using human breast cancer cells, scientists from the Johns Hopkins Kimmel Cancer Center have potentially […]
Researchers from the Johns Hopkins Kimmel Cancer Center have identified key markers in pancreatic cancer progession using a […]
Listen to an audio article about the new federal mandate on breast density notification. The mandate, part of […]
On September 10, 2024 the federal mandate on breast density notification takes effect. The mandate, part of the […]
A study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have identified […]
Una nueva prueba desarrollada por investigadores del Centro Oncológico Kimmel de Johns Hopkins podría brindar a los gastroenterólogos información…
Utilizando técnicas de ingeniería genética, los investigadores del Centro Oncológico Kimmel de Johns Hopkins…
Se aprobó un nuevo fármaco para el tratamiento de un tipo de cáncer cerebral, llamado glioma de bajo grado con mutación IDH…
